Skip to content

Randomized Trial of Depression Follow-up Care by Email

Randomized Trial of E-mail Follow-up Care After Cognitive Behavioural Treatment for Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01449890
Enrollment
92
Registered
2011-10-10
Start date
2012-09-30
Completion date
2013-11-30
Last updated
2015-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorders

Keywords

follow up care, e-mail, effectiveness, depressive disorders

Brief summary

The primary objective of this study is to test in a randomized effectiveness trial if e-mail delivered cognitive behavioural treatment is an effective follow-up care approach in the treatment of depression under clinically representative conditions.

Detailed description

Depression belongs to the most prevalent mental disorders and often goes along with a high burden of disease. Although the efficacy and the effectiveness of psychological treatments for depressive disorders have been demonstrated, there remains the problem of maintaining the benefits achieved during the initial treatment phase. Therefore options of follow-up care have to be considered. Since access to psychotherapeutic treatments is limited and costly, internet-based interventions can offer a feasible opportunity for follow-up care in order to enhance the long-term effectiveness of psychotherapy.

Interventions

BEHAVIORALE-mail follow up care

After having terminated inpatient CBT patients receive follow up care by email for 12 weeks (on average one contact per week). The follow up care aims at supporting the patients in continuing exercises in order to cope with depression.

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Depressive disorder: F32.0-F32.2; F33.0-F33.2; F34.1 according to ICD-10 * Precursory CBT * Internet access

Exclusion criteria

* No knowledge of the German language * Risk of suicide * Acute psychosis or psychotic symptoms * Established concurrent in vivo CBT after discharge from inpatient CBT

Design outcomes

Primary

MeasureTime frame
Measure of the severity of depression - Beck Depression Inventory (BDI- II)Change in the BDI-II from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care)

Secondary

MeasureTime frameDescription
Measure of health related quality of life - SF-8Change in the SF-8 from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up careSF-8: short version of the SF -36
GAD-7Change in the GAD-7 from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care)Measure for generalized anxiety disorder
Depressive relapse/recurrenceMeasured at follow up (3 months after termination of the follow-up care)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026